Toroso Investments, LLC Biomarin Pharmaceutical Inc Transaction History

Toroso Investments, LLC

$8.31 Billion
Q3 2024

A detailed history of Toroso Investments, LLC transactions in Biomarin Pharmaceutical Inc stock. As of the latest transaction made, Toroso Investments, LLC holds 30,467 shares of BMRN stock, worth $2.03 Million. This represents 0.03% of its overall portfolio holdings.

Number of Shares

30,467

Previous 30,467 -0.0%

Holding current value

$2.03 Million

Previous $2.14 Million -0.0%

% of portfolio

0.03%

Previous 0.03%

18 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2024 Nov 14, 2024	BUY	$69.02 - $93.84 $1.26 Million - $1.72 Million	18,300 Added 150.41%	30,467 $2.14 Million
Q2 2024 Aug 14, 2024	SELL	$74.43 - $92.22 $392,990 - $486,921	-5,280 Reduced 30.26%	12,167 $1 Million
Q1 2024 May 15, 2024	BUY	$83.81 - $99.0 $578,791 - $683,694	6,906 Added 65.52%	17,447 $1.52 Million
Q4 2023 Feb 14, 2024	BUY	$76.22 - $98.51 $4,192 - $5,418	55 Added 0.52%	10,541 $1.02 Million
Q3 2023 Nov 15, 2023	BUY	$85.07 - $94.48 $48,319 - $53,664	568 Added 5.73%	10,486 $927,000
Q2 2023 Aug 14, 2023	BUY	$86.68 - $100.3 $325,916 - $377,128	3,760 Added 61.06%	9,918 $860,000
Q1 2023 May 15, 2023	BUY	$87.74 - $117.27 $34,043 - $45,500	388 Added 6.72%	6,158 $599,000
Q4 2022 Feb 15, 2023	BUY	$80.93 - $108.63 $58,188 - $78,104	719 Added 14.23%	5,770 $597,000
Q3 2022 Nov 23, 2022	BUY	$82.16 - $96.94 $23,333 - $27,530	284 Added 5.96%	5,051 $428,000
Q2 2022 Aug 15, 2022	SELL	$71.48 - $86.85 $1,787 - $2,171	-25 Reduced 0.52%	4,767 $395,000
Q1 2022 May 20, 2022	BUY	$74.28 - $92.69 $35,208 - $43,935	474 Added 10.98%	4,792 $369,000
Q4 2021 Feb 16, 2022	BUY	$71.72 - $91.47 $14,630 - $18,659	204 Added 4.96%	4,318 $381,000
Q3 2021 Nov 15, 2021	BUY	$74.77 - $85.47 $48,974 - $55,982	655 Added 18.94%	4,114 $318,000
Q2 2021 Aug 13, 2021	SELL	$75.51 - $84.79 $1,887 - $2,119	-25 Reduced 0.72%	3,459 $289,000
Q1 2021 May 17, 2021	BUY	$74.73 - $90.69 $76,448 - $92,775	1,023 Added 41.57%	3,484 $263,000
Q4 2020 Feb 16, 2021	BUY	$72.61 - $90.2 $178,693 - $221,982	2,461 New	2,461 $216,000
Q3 2020 Nov 16, 2020	SELL	$71.87 - $131.03 $118,801 - $216,592	-1,653 Closed	0 $0
Q2 2020 Aug 17, 2020	BUY	$79.55 - $124.22 $131,496 - $205,335	1,653 New	1,653 $204,000

Others Institutions Holding BMRN

# of Institutions

637

Shares Held

177M

Call Options Held

2.01M

Put Options Held

1.28M

View Full List

About BIOMARIN PHARMACEUTICAL INC

Ticker BMRN
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 185,824,000
Market Cap $12.4B
Description
BioMarin Pharmaceutical Inc. develops and commercializes therapies for people with serious and life-threatening rare diseases and medical conditions. Its commercial products include Vimizim, an enzyme replacement therapy for the treatment of mucopolysaccharidosis (MPS) IV type A, a lysosomal storage disorder; Naglazyme, a recombinant form of N-a...

More about BMRN

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Toroso Investments, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Toroso Investments, LLC with notifications on news.

Account

Toroso Investments, LLC Biomarin Pharmaceutical Inc Transaction History